Ginkgo Biloba Vs Desmopressin in Treatment of Children with Monosymptomatic Nocturnal Enuresis

Launched by MENOUFIA UNIVERSITY · Jan 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of two different treatments for children who experience bedwetting at night, known as monosymptomatic nocturnal enuresis. The trial is comparing a natural supplement called Ginkgo Biloba with a medication called desmopressin. The goal is to see which treatment works better in helping children stop bedwetting.

Children aged 18 to 26 and those between 65 to 74 years old who have this specific type of bedwetting may be eligible to participate. However, children who also wet during the day won't be included in the study. If a child joins the trial, they will receive one of the two treatments and be monitored to see how well it helps reduce or eliminate bedwetting. This trial is currently recruiting participants, so it's a great opportunity for families looking for solutions to this common issue.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all children with monosymptomatic nocturnal enuresis.
• Exclusion Criteria:
• • children with day and night wetting.